Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

OBJECTIVE: Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the incomplete understanding of the pathogenic mechanisms and the absence of accurate non-invasive biomarkers. The aim of this study was to identify novel NAFLD therapeutic targets andbiomarkers by conducting liver...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut
Main Authors: Baselli, Guido Alessandro, Dongiovanni, Paola, Rametta, Raffaela, Meroni, Marica, Pelusi, Serena, Maggioni, Marco, Badiali, Sara, Pingitore, Piero, Maurotti, Samantha, Montalcini, Tiziana, Taliento, Alice Emma, Prati, Daniele, Rossi, Giorgio, Fracanzani, Anna Ludovica, Mancina, Rosellina Margherita, Romeo, Stefano, Valenti, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Hepatology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497582/
https://ncbi.nlm.nih.gov/pubmed/32001554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados